The Rose Research Center (RRC) is a state-of-the-art research facility with two locations in North Carolina. Each office is specially equipped with staff, technology, and services to conduct the broadest spectrum of study protocols. The Center specializes in tobacco dependence research including research on smokers, addiction, smoking cessation, tobacco harm reduction and the use of other tobacco products.
RRC employs highly qualified individuals and focuses on a safety-centric approach to all clinical trials. Members of our staff have extensive experience in statistically valid study design, clinical trials, data management, and participant recruitment and retention. Rose Research Center ensures that sponsors receive the highest quality experience.
Rose Research Center also maintains a proprietary database of potential research participants in addition to contractual relationships with industry partners to ensure an optimal recruitment process.
“In establishing the Rose Research Center, my goal was to create a unique organization that can skillfully and efficiently conduct clinical evaluations of products designed to promote smoking cessation and tobacco harm reduction. This Center represents an exciting outgrowth of my 35 years of research into nicotine and tobacco dependence and smoking cessation treatment. We stress innovation in device and pharmaceutical development, and we offer the capability to conduct phase I, II and III trials of novel therapeutic approaches. The Center’s key leadership has a long history and unique expertise in clinical study design, assessment of cigarette smoking behavior and smoking cessation treatment. By furthering the development of alternatives to cigarette smoking, our long range goal is the elimination of tobacco related disease.”
Clinical trials are research studies designed to answer specific questions about safety and effectiveness of investigational drugs, medical devices, procedures or behavioral changes. In most cases clinical trials compare a new medical approach to an existing one or to a placebo. A placebo is an inactive substance that looks the same as the active substance. Clinical trials can also be conducted on medications that are already approved by the FDA to determine if they may be useful for another condition, or to determine the safety or effectiveness of long-term use.
Volunteers may gain access to new research treatments before they are widely available. Additionally, volunteering leads to new drug discoveries, better treatment outcomes and ultimately can save countless lives. You may be among the first to benefit if the approach being studied is found to be helpful.
Dr. Jed Rose is the President and CEO of the Rose Research Center. He is also Director of the Duke Center for Smoking Cessation and a Professor in the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center. Dr. Jed Rose began work in the area of tobacco addiction research as a NIMH Postdoctoral fellow at the University of California at Los Angeles. A main focus of his research program has been the elucidation of the role of sensorimotor cues and the CNS effects of nicotine in reinforcing cigarette smoking behavior. He is co-inventor of the nicotine skin patch and other treatments for smoking cessation. His primary research goals are to elucidate the biological mechanisms underlying tobacco addiction and to promote the development of more effective treatments.
Participant information is maintained in a volunteer database system and retained for future studies as they become available.
Pertinent information is confidentially kept on file to aid in selecting highly qualified candidates for research studies.